Biosynex SA (ALBIO.PA)

12.52 €

-0.06 (-0.48%)
Rating:
Recommendation:
-
Symbol ALBIO.PA
Price 12.52 €
Beta -2.000
Volume Avg. 0.02M
Market Cap 133.158M
Shares () -
52 Week Range 10.62-21.84
1y Target Est -
DCF Unlevered ALBIO.PA DCF ->
DCF Levered ALBIO.PA LDCF ->
ROE 0.72% Neutral
ROA 0.39% Neutral
Operating Margin -
Debt / Equity 41.79% Neutral
P/E 2.05 Buy
P/B 0.65 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Thierry Paper
Healthcare
Diagnostics & Research
Paris

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.